Table 2.
Univariate analysis of median change in HbA1c between 2016 and following flash monitoring prescription (mmol/mol and %)
Change in HbA1c | n | P value | |
Male | −2 (−8–4) | 900 | |
−0.2 (−0.7–0.4) | |||
Female | −1 (− 8–6) | 900 | 0.015 |
−0.1 (−0.7–0.6) | |||
CSII | −1 (−6–4) | 1360 | |
−0.1 (−0.6–0.4) | |||
MDI | −1 (−9–5) | 440 | 0.246 |
−0.1 (−0.8–0.5) | |||
SIMD quintile 1 | +1 (−8–8) | 145 | |
+0.1 (−0.7–0.7) | |||
SIMD quintile 2–5 | −1 (−8–5) | 1611 | 0.021 |
−0.1 (−0.7–0.5) | |||
Early flash monitoring start | −2 (−8–4) | 751 | |
−0.2 (−0.7–0.4) | |||
Later flash monitoring start | −1 (−8–6) | 1049 | 0.013 |
−0.1 (−0.7–0.6) | |||
HbA1c on target at baseline (<58 mmol/mol (7.5%)) | +2 (−2–8) | 613 | |
+0.2 (−0.2–0.7) | |||
HbA1c above target at baseline (≥58 mmol/mol (7.5%)) | −4 (−11–2) | 1187 | <0.001 |
−0.4 (−1.0–0.2) | |||
DAFNE | −2 (−8–4) | 644 | |
−0.2 (−0.7–0.4) | |||
No DAFNE | −1 (−8–5) | 1156 | 0.033 |
−0.1 (−0.7–0.5) | |||
Two sensors or more collected per month | −2 (−8–4) | 1535 | |
−0.2 (−0.7–0.4) | |||
Fewer than two sensors collected per month | +1 (−8–7) | <0.001 | |
+0.1 (−0.7–0.6) | 265 |
Data are median (IQR).
CSII, continuous subcutaneous insulin infusion; DAFNE, Dose Adjustment for Normal Eating; HbA1c, hemoglobin A1c; MDI, multiple daily injection; SIMD, Scottish Index of Multiple Deprivation.